MXCT vs VFC
MaxCyte Inc (MXCT) versus VF Corporation (VFC) — a side-by-side from cached financials, not a winner call.
MaxCyte Inc (MXCT) is a medical devices company listed on NASDAQ.
VF Corporation (VFC) is a apparel manufacturing company listed on NYSE.
Latest reported MXCT revenue for 2024-12-31 was $38.6M. Net income was -$41.1M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. MXCT currently screens at market cap $124.3M.
Latest reported VFC revenue for 2025-03-29 was $9.50B. Net income was -$189.7M. Revenue was down 4.1% from 2024-03-30 to 2025-03-29. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
MXCT currently screens at market cap $124.3M. VFC currently screens at market cap $6.55B and trailing P/E 26.1.
Not investment advice. Open the MXCT and VFC stock pages for the full models.
Not investment advice.